Finance

Lists
Why is OTLK down 2.88%?
Dive Deeper
OTLK:NASDAQ
Outlook Therapeutics Inc
$0.62
-2.88%
(-0.018) 1D
$0.63
+2.01% (+0.012)
Pre-market
Closed: Sep 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OTLK...
Open
$0.63
High
$0.64
Low
$0.60
Mkt. cap
151.09M
Avg. vol.
13.32M
Volume
8.57K
52-wk high
$2.54
52-wk low
$0.16
EPS
-$0.87
Beta
0.74
Shares outstanding
243.45M
No. of employees
17
Open
$0.63
High
$0.64
Low
$0.60
Mkt. cap
151.09M
Avg. vol.
13.32M
Volume
8.57K
52-wk high
$2.54
52-wk low
$0.16
EPS
-$0.87
Beta
0.74
Shares outstanding
243.45M
No. of employees
17
News stories
From web sources and news partners
About Outlook Therapeutics Inc
CEO-
Employees17
Founded2010
Headquarters-
SectorBiotechnology
Websiteoutlooktherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to OTLK in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OTLK in the last 3 months.
Highest
Current $0.62
$10.50 (+1,590.55%)
Average
$5.37 (+764.60%)
Lowest
$1.60 (+157.61%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
$10.50
+1,590.5%
09/10/2026
Julian Harrison
BTIG
Buy
Reiterated
$4.00
+544%
08/14/2026
Douglas Tsao
H.C. Wainwright
Hold
Reiterated
$1.60
+157.6%
07/28/2026
Daniil Gataulin
Chardan Capital
Hold
Maintained
$1.00
+61%
01/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-91.79K
-1.21M
127.44K
8.70K
Cost of goods sold
916.52K
29.63K
149.33K
16.96K
Cost of revenue
916.52K
29.63K
149.33K
16.96K
Research and development expenses
5.98M
3.63M
4.50M
3.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.33M
8.61M
9.50M
7.55M
Operating expense
16.31M
12.25M
14.01M
10.80M
Total operating expenses
17.22M
12.28M
14.15M
10.82M
Operating income
-17.31M
-13.48M
-14.03M
-10.81M
Other non operating income
3.02M
-2.79M
6.84M
-7.04M
EBT including unusual items
-14.85M
-23.06M
-4.45M
-20.32M
EBT excluding unusual items
-14.51M
-16.31M
-7.23M
-17.89M
Income tax expense
-1.55M
-
-
-
Effective tax rate
10.47%
-
-
-
Other operating expenses
-
-
-
-
Net income
-13.29M
-23.06M
-4.45M
-20.32M
Net profit margin
14,482.19%
1,909.05%
-3,494.28%
-233,554.85%
Earnings per share
-0.29
-0.22
-0.17
-0.09
Interest and investment income
89.74K
-
3.00
7.00
Interest expense
-264.16K
-
-
-
Net interest expenses
-174.42K
-
3.00
7.00
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.28M
-13.45M
-14.00M
-10.80M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps